2 recruiting, 2 unknown, 1 completed, 1 withdrawn. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Recruiting 2, Unknown 2, Completed 1, Withdrawn 1 |
Follow Margins of Excision: new trials by email Literature Review of Margins of Excision trials Research Report on Margins of Excision
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma Comprehensive Therapy Based on Tumor Stage, IMRT with Primary Clinical Target Volume Based on Margin Expansion, IMRT with Consensus Primary Clinical Target Volume - Non-metastatic Nasopharyngeal Carcinoma | Phase 3 | Recruiting | Sun Yat-sen University | 568 | 2026-07-24 | 2026-08-19 |
| Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement Placebo for Risankizumab, Risankizumab - Psoriasis | Phase 3 | Completed | AbbVie | 174 | 2021-02-26 | 2024-06-14 |
| Induction Chemotherapy for Locally Recurrent Rectal Cancer Combination drug, Chemoradiotherapy, Surgery locally recurrent rectal cancer - Recurrent Rectal Cancer | Phase 3 | Recruiting | Catharina Ziekenhuis Eindhoven | 364 | 2020-11-13 | 2022-09-06 |
| Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy Bracketing, Neoadjuvant therapy, Post-treatment volume margin resection - Breast Cancer | Phase 3 | Unknown | Mansoura University | 370 | 2019-08-01 | 2021-02-25 |
| Interest of Indocyanine Green in Neoplastic Prostatic Tissue indocyanine green infusion - Prostatic Neoplasms | Phase 3 | Withdrawn | Centre Hospitalier Universitaire de Saint Etienne | 2014-04-01 | 2016-03-10 | |
| Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL Fluorescence visualization device - Oral Cancer, High-grade Precancer | Phase 3 | Unknown | University of British Columbia | 200 | 2013-01-01 | 2014-09-10 |
Breast Neoplasms (1) · Mouth Neoplasms (1) · Prostatic Neoplasms (1) · Psoriasis (1) · Rectal Neoplasms (1) · Recurrence (1)
Morphological and Microscopic Findings (6) · Pathological Conditions, Signs and Symptoms (6) · Neoplasms (4) · Neoplasms by Site (4) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Breast Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Disease Attributes (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Genital Diseases, Male (1)
Chemoradiotherapy (1) · Drug Combinations (1) · Folfox protocol (1) · IFL protocol (1) · Neoadjuvant Therapy (1) · Radiotherapy, Intensity-Modulated (1) · risankizumab (1)
AbbVie (1) · Catharina Ziekenhuis Eindhoven (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Mansoura University (1) · Sun Yat-sen University (1) · University of British Columbia (1)
Canada (2) · Belgium (1) · China (1) · Egypt (1) · Netherlands (1) · Norway (1) · Portugal (1) · Puerto Rico (1) · Spain (1) · Sweden (1) · United States (1)
Calum MacAulay, Ph.D (1) · Catherine Poh, DDS, PhD (1) · Donald Anderson, Dr. (1) · John Yoo, Dr. (1) · Joseph Dort, Dr. (1) · Jun Ma, Prof. (1) · Karen Kost, Dr. (1) · Kenneth Berean, Dr. (1) · Kevin Higgins, Dr. (1) · Kitty Corbett, Ph.D (1) · Michele Williams, DDS (1) · Mike Odell, Dr. (1) · Miriam Rosen, Ph.D (1)
PMID 22026481, PMID 33034628, PMID 39208985
2014 (1)